Hillary Johnston-Cox, MD, PhD
@hjcox_pvd
Followers
583
Following
2K
Media
17
Statuses
2K
Vascular Medicine, Interventional Cardiologist @Northwell, Alumni @PennCardiology @IcahnMountSinai @BUSM, #peripheralinterventions #limbsalvage #PADprevention
Manhattan, NY
Joined March 2010
POLY-HF trial: Polypill containing metoprolol, spironolactone, and empagliflozin improved EF, QoL, and adherence, and reduced HF hospitalizations at 6 months in HFrEF patients compared to usual care. #AHA25 View the slides here: https://t.co/98PJIQpLRQ
1
80
188
A contemporary look into spontaneous coronary artery dissection: The SwissSCAD Registry. With one-in-ten patients suffering an in-hospital MACE surveillance after presentation is important @DegrauweSophie @fahrni_gregor @S_Cook_unifr @GillhoferThomas
https://t.co/HBYCnpMpc7
ahajournals.org
0
4
14
The impact of cancer site on outcomes in patients with acute VTE The #RIETEregistry experience
0
16
40
Join our @ACCinTouch #Prevention Council & renowned experts for a practical review of the new #Hypertension guidelines @ 1pm on 9/17. @DrEugeneYang Dr. Joseph Ebinger @Lesliedavis @EileenHandberg Dr. Keith Ferdinand @American_Heart @nationallipid @ASPCardio
0
8
29
Peripheral ischemia accelerates cancer growth by increasing inflammaging of hematopoietic stem cells, and these changes to antitumoral immunity are long-lasting. Read more: https://t.co/uenk65TdK9
#JACCCardioOnc #CardioOnc @JACCJournals
0
24
63
👩⚕️👨⚕️ Fellows, this is where your #InterventionalCardiology career takes off. At #SCAIFellows Courses on Dec. 10–14 in Miami, you’ll get: ✔️ Hands-on training ✔️ Real-world case discussions ✔️ Mentorship from leaders in the field and more! Apply for scholarship today➡️
0
8
27
Amazing job @NicholeBrunton leading a comprehensive review on #IntermediateRiskPE! A must read for all #PE enthusiasts. @dinubalanescu @MayoClinicCV @mnyoung1 @EricSecemskyMD @SVM_tweets @ACCinTouch
#mdpijcm
#HighlyReviewed Views 20678, Citations 13🙌 Risk Stratification and Management of Intermediate-Risk #Acute_Pulmonary_Embolism 👉 https://t.co/Evlg6qKV1W
@MediPharma_MDPI by Nichole Brunton et al. @stanhenkin
@NicholeBrunton
0
5
12
Thinking about a career in vascular medicine? It’s one of the most exciting—and evolving—fields in cardiology. Join @ACCinTouch on August 4th for a webinar: “Navigating Career Pathways in Vascular Medicine". 🔗 https://t.co/FrPFpPBx5L
#VascularMedicine #CardiologyCareers
0
4
7
Join us for the upcoming webinar “Navigating Career Pathways in Vascular Medicine” hosted by American College of Cardiology @ACCinTouch in collaboration with Society of Vascular Medicine @SVM_tweets August 4th, 7 pm EST. Learn more & Register here: https://t.co/YIfzuln4KX
0
5
10
Renal denervation for HTN was approved the FDA over 18 months ago. But very few cases performed in the US despite a theoretical eligible population >100M patients for this therapy. We cover the elephant in the room: reimbursement in @cardiacinterv. https://t.co/5OdKP7YEe6
citoday.com
As renal denervation is adopted across the United States for patients with uncontrolled or resistant hypertension, the dubious state of reimbursement presents a barrier to both health systems and...
0
18
70
This great #coronaryDissection paper addressing #CoronaryDCB on #DenovoLesions mirrors #PeripheralDCB outcomes in #PVI 💎#NoDCB without #CoronaryImaging Gotta love it when things make sense in our growing #CVinterventionalField !
In denovo treated with #DCB 🔑 predict #TLF 🟠#HDialysis 🟡severely #calcified 🔴absence of #MedialDissection Full paper 👉 https://t.co/mw7QOKT52Z
@HadyLichaaMD @MGtberg @AlkashkariWail @mirvatalasnag @jedicath @dimitri_zappi @KPujdak @MatthiasBossard @mate2k @evandrofilhobr
1
5
13
Acetylcholine provocation testing. How does dosing affect the diagnostic performance in the detection of coronary spasm in ANOCA? @RajanRehan23 #Cardiotwitter #AHAJournals
https://t.co/OE425kPBf2
0
12
23
With echo boards coming up how about some Echo Hemodynamics?? ❤️Here is a great resource for all you studying for echo boards on common hemodynamic equations used in echocardiography. One of my favorite parts of echo is the amount of hemodynamic data you can obtain non
0
12
25
ARIVA trial compared 6mo riva vs riva + ASA after venous stent for PTS. ♥️ No difference in patency 💙 No difference in PTS symptoms ♥️ Patency rate was 94% at 6 months - much higher than expected 💙 Trial stopped early for futility Published in @circulation in March #ISTH2025
0
6
6
Unhealthy weight has been linked to 60+ conditions, including heart risk factors, #CVD, #cvMI and #Stroke. Download the latest #CardioSmart infographic supporting the ACC’s new Concise Clinical Guidance on medical weight management. Learn more: https://t.co/j45X0HQW3d
3
29
48
🔴Pulmonary Hypertension: Updates in Diagnosis and Management⤵️ #2025commentary #openaccess 🔹 https://t.co/NM0T6MI8wb
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX
0
74
255
No change in post-thrombotic syndrome indices or stent thrombosis with #DOAC vs #DOAC + ASA after venous stent: ARIVA trial @Vasculearn @AnticoagForum @PERTConsortium @ThrombosisCan @ThrombosisUK @canvector @EuropeanTHA
0
5
12
Wonderful work led by @AhmadJabri8 describing the use of #SCAISHOCKStages in pts w/ PE. @SrihariNaiduMD @NavinKapur4 @jaygirimd @SripalBangalore @herbaronowMD @vikasaggarwalmd Link: https://t.co/MxgOBMQ8fa
2
15
72
🩸 New insights from the RENOVE trial (extended duration anticoagulation) at #ISTH2025: 📉 Reduced-dose DOAC is non-inferior in patients with BMI <30, with less bleeding risk. ⚠️ But in patients with BMI ≥30, reduced-dose may be inferior for bleeding and recurrent VTE. ➡️
3
37
88
Right heart catheterization in heart failure: indications, interpretation, and pitfalls https://t.co/xtlqYWdE9D
#CardioEd #EHJ @ESC_Journals @escardio
2
62
193